Published in J Natl Cancer Inst on May 01, 1980
Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor. Mol Cell Biol (1983) 1.32
Identification of asparagine-linked oligosaccharides involved in tumor cell adhesion to laminin and type IV collagen. J Cell Biol (1984) 1.01
In vivo horizontal oncogenesis by a human tumor in nude mice. Proc Natl Acad Sci U S A (1982) 0.94
Asparagine-linked oligosaccharides in murine tumor cells: comparison of a WGA-resistant (WGAr) nonmetastatic mutant and a related WGA-sensitive (WGAs) metastatic line. J Cell Biol (1984) 0.89
Tumor cell surface beta 1-4-linked galactose binds to lectin(s) on microvascular endothelial cells and contributes to organ colonization. J Cell Biol (1990) 0.84
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (1978) 6.59
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest (2000) 5.52
Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res (1993) 3.59
Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect Immun (1978) 3.24
Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res (1995) 3.11
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
An economic appraisal of alternative pre-natal screening programmes for Down's syndrome. J Public Health Med (1993) 2.92
Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science (1987) 2.86
E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J Cell Biol (1998) 2.81
Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis. Cancer Res (2001) 2.78
Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant or susceptible mice. Infect Immun (1978) 2.65
T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63
Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant (2004) 2.36
Enhanced immune responsiveness to a thymus-independent antigen early after adult thymectomy: evidence for short-lived inhibitory thymus-derived cells. Eur J Immunol (1972) 2.34
B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J Exp Med (1979) 2.28
Comparison of direct immunofluorescence and direct immunoperoxidase procedures for detection of herpes simplex virus antigen in lesion specimens. J Clin Microbiol (1983) 2.27
Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation. J Clin Microbiol (1978) 2.26
Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J Natl Cancer Inst (1994) 2.25
T-T interactions in the induction of suppressor and helper T cells: analysis of membrane phenotype of precursor and amplifier cells. J Exp Med (1977) 2.22
Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med (1981) 2.18
The possible biological significance of Fc receptors on mammalian lymphocytes and tumor cells. Cell (1974) 2.12
Murine lymphocyte surface antigens. Adv Immunol (1979) 2.04
In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection. Cell Immunol (1982) 1.97
Autogenous regulation of transcription termination factor Rho and the requirement for Nus factors in Bacillus subtilis. Mol Microbiol (1999) 1.95
Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem Biophys Res Commun (1999) 1.93
A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera. J Immunol Methods (1978) 1.91
Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. Eur J Cancer (1996) 1.84
Characterization of antibodies produced in natural and experimental coxsackievirus infections. J Immunol (1968) 1.81
Variable effects of anti-lymphocyte serum on humoral antibody formation: role of thymus dependency of antigen. J Immunol (1971) 1.80
Modified hemagglutination-inhibition test for rubella employing human group O erythrocytes. Appl Microbiol (1972) 1.77
Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci U S A (1993) 1.76
Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med (1995) 1.70
Which T cells cause graft rejection? Transplantation (1982) 1.69
"B"-cell stimulation of allogeneic T-cell proliferation in mixed lymphocyte cultures. Nat New Biol (1973) 1.68
TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J Cell Biol (1992) 1.66
CB2 receptors in the brain: role in central immune function. Br J Pharmacol (2007) 1.66
Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nat Med (1996) 1.66
A cancer therapy resistant to resistance. Nature (1997) 1.65
Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol (1992) 1.64
On the nature of complement-fixing antibodies to Mycoplasma pneumoniae. J Immunol (1966) 1.63
Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci U S A (1993) 1.63
Cognitive behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst Rev (2002) 1.59
Comparison of immunofluorescence and immunoperoxidase staining for identification of rubella virus isolates. J Clin Microbiol (1978) 1.59
Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs (1995) 1.58
MUC1 cross-reactive Gal alpha(1,3)Gal antibodies in humans switch immune responses from cellular to humoral. Nat Med (1998) 1.58
Mouse macrophage beta subunit (CD11b) cDNA for the CR3 complement receptor/Mac-1 antigen. Immunogenetics (1990) 1.58
Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression. Proc Natl Acad Sci U S A (1991) 1.54
Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J Immunother (2001) 1.52
Ir gene function in an I-A subregion mutant B6.C-H-2bm12. J Exp Med (1981) 1.51
Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature (1982) 1.48
Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses. J Immunol (1980) 1.48
Tissue expression, structure and function of the murine Ly-6 family of molecules. Immunol Cell Biol (1995) 1.48
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer (1997) 1.48
Micro-processors, macro-economic policy, and public health. Lancet (1979) 1.47
Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc Natl Acad Sci U S A (1998) 1.47
Detection and significance of occult metastases in node-negative breast cancer. Br J Surg (1993) 1.47
Very early neonatal seizure rate: a possible epidemiological indicator of the quality of perinatal care. Br J Obstet Gynaecol (1982) 1.46
Peptide mimics of a tumor antigen induce functional cytotoxic T cells. Nat Biotechnol (1998) 1.46
Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Cancer Res (1997) 1.45
Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells. J Clin Microbiol (1976) 1.45
The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology (1990) 1.45
Lesions in the blood supply of the papilla in experimental analgesic nephropathy. Med J Aust (1968) 1.42
Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Cancer Res (2000) 1.42
Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res (1991) 1.41
Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection. J Exp Med (1980) 1.41
Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J Clin Invest (1997) 1.40
Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev (1994) 1.40
Mucins: structure, function, and associations with malignancy. Bioessays (1992) 1.40
Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev (1995) 1.39
Molecular cloning of a human immunoglobulin G Fc receptor. Proc Natl Acad Sci U S A (1988) 1.38
Neonatal convulsions: aetiology, late neonatal status and long-term outcome. Dev Med Child Neurol (1978) 1.38
Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol (1993) 1.37
Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations. Cancer Res (1988) 1.36
Partial primary structure of the T4 antigens of mouse and sheep: assignment of intrachain disulfide bonds. Proc Natl Acad Sci U S A (1986) 1.36
Monoclonal antibodies to the murine Ly-2.1 cell surface antigen. Immunology (1982) 1.35
Deposits of immunoglobulin and fibrin in human allografted kidneys. Lancet (1968) 1.35
Assessment of mitotic thymus-derived lymphocytes by their sensitivity to the cytotoxic effects of anti-theta serum. Cell Immunol (1974) 1.35
Rubella virus hemagglutination with a wide variety of erythrocyte species. Appl Microbiol (1971) 1.34
Physical and immunologic properties of rubella antigens. J Immunol (1968) 1.33
Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera. Cell Immunol (1977) 1.33
Visual reading of enzyme immunofluorescence assays for human cytomegalovirus antibodies. J Clin Microbiol (1980) 1.32
Polymorphic expression of CD46 protein isoforms due to tissue-specific RNA splicing. Mol Immunol (1993) 1.32
Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor. Mol Cell Biol (1983) 1.32
Heterogeneous vascular dependence of tumor cell populations. Am J Pathol (2001) 1.31
Ly-4, a new locus determining a lymphocyte cell-surface alloantigen in mice. Proc Natl Acad Sci U S A (1973) 1.30
Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat Struct Biol (1999) 1.29
Physical exercise for sleep problems in adults aged 60+. Cochrane Database Syst Rev (2002) 1.28
Psychiatric disorder among children with tuberous sclerosis. Dev Med Child Neurol (1987) 1.28
Role of the mannose receptor in the immune response. Curr Mol Med (2001) 1.28
Identification and quantification of complement regulator CD46 on normal human tissues. Immunology (1993) 1.28
Antibody production in immunosuppressed recipients of renal allografts. Lancet (1969) 1.28
Cognitive behavioural interventions for sleep problems in adults aged 60+. Cochrane Database Syst Rev (2003) 1.27
Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells. J Cell Biol (2000) 1.27
Hemadsorption and hemadsorption inhibition tests for rubella virus. Arch Gesamte Virusforsch (1968) 1.27
Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas. Am J Pathol (1994) 1.27
Cooperation between mouse T-cell subpopulations in the cell-mediated response to a natural poxvirus pathogen. Cell Immunol (1976) 1.26
Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. Cancer Res (1983) 1.24
Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H-2 incompatible parental strain. Int J Cancer (1978) 1.24